Yoshinobu Iwasaki

Kodaira, JP 
Kodaira, JP 

Overview

Yoshinobu Iwasaki practices practicing medicine in Kodaira, Japan.

His clinical expertise encompasses Hypereosinophilic Syndrome, Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, and Reticulohistiocytoma.

He is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Kodaira, Japan
Other Locations
Tokyo, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: May 18, 2026
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3

11 Total Publications

Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
Journal: Thoracic cancer
Published: February 11, 2021

Frequently Asked Questions about Yoshinobu Iwasaki

Is Yoshinobu Iwasaki a top-rated expert for Hypereosinophilic Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Yoshinobu Iwasaki is classified as an Experienced expert for Hypereosinophilic Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yoshinobu Iwasaki participate in research or clinical trials?

Yes. Yoshinobu Iwasaki has published 11 articles and abstracts on conditions like Hypereosinophilic Syndrome. You can view a list of Yoshinobu Iwasaki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Iwasaki's expertise for a condition
ConditionClose
        View All 8 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile